title: Dantrolene use in 3,4-methylenedioxymethamphetamine (ecstasy)-mediated hyperthermia.
authors.forename: Daniel E
authors.initials: DE
authors.lastname: Rusyniak
authors.forename: Matthew L
authors.initials: ML
authors.lastname: Banks
authors.forename: Edward M
authors.initials: EM
authors.lastname: Mills
authors.forename: Jon E
authors.initials: JE
authors.lastname: Sprague
mesh_terms: D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D003620:Dantrolene / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006213:Hallucinogens / Q000009:adverse effects*; D008305:Malignant Hyperthermia / Q000188:drug therapy*; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects*; D051381:Rats; D019837:Ryanodine Receptor Calcium Release Channel / Q000187:drug effects; D013552:Swine
chemical_list: D006213:Hallucinogens; D009125:Muscle Relaxants, Central; D019837:Ryanodine Receptor Calcium Release Channel; D003620:Dantrolene; D018817:N-Methyl-3,4-methylenedioxyamphetamine